Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks

Pharmacogenetics

Volumn 6, Issue 2, 1996, Pages 187-191

  Chen, Chun Lin ^a   Liu, Qing ^a   Relling, Mary V ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

glutathione S transferase; GSTM1; GSTT1; polymorphism

Indexed keywords

BETA GLOBIN; DNA; GLUTATHIONE TRANSFERASE; ISOENZYME;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE; TECHNIQUE; VOLUNTEER;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BASE SEQUENCE; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE DELETION; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; UNITED STATES;

EID: 0029881659     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199604000-00005     Document Type: Article

References (22)

1. Alexandrie A-K, Sundberg MI, Seidegard J, Tornling G, Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 1994: 15, 1785-1790.
2. Andersson C, Mosialou E, Weinander R, Morgenstern R. Enzymology of microsomal glutathione S-transferase. Adv Pharmacol 1994: 27, 19-35.
3. Bell DA, Thompson CL, Taylor J, Miller CR, Perera F, Hsieh LL, Lucier GW. Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: Application to glutathione transferase mu. Environ Health Perspect 1992: 98, 113-117.
4. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increase susceptibility to bladder cancer. J Natl Cancer Inst 1993: 85, 1159-1164.
5. Brockmöller J, Gross D, Kerb R, Drakoulis N, Nitz M, Roots I. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class μ gene detected by polymerase chain reaction. Biochem Pharmacol 1992: 43, 647-650.
6. Brockmöller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and Ψ in lung cancer patients and controls. Cancer Res 1993: 53, 1004-1011.
7. Brockmöller J, Kerb R, Drakoulis N, Staggeldt B, Roots I. Glutathione S-transferase Ml and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994: 54, 4103-4111.
8. Guengerich FP. Metabolism and genotoxicity of dihaloalkanes. Adv Pharmacol 1994: 27, 211-236.
9. Guengerich FP, Thier R, Persmark M, Taylor JB, Pemble SE, Ketterer B. Conjugation of carcinogens by θ class glutathione S-transferase: mechanisms and relevance to variations in human risk. Pharmacogenetics 1995: 5, S103-107.
10. Heagerty AH, Fitzgerald D, Smith A, Bowers B, Jones P, Fryer AA, Zhao L, Alldersea J. Strange RC. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumors. Lancet 1994: 343, 266-268.
11. Ketterer B, Christodoulides LG. Enzymology of cytosolic glutathione S-transferase. Adv Pharmacol 1994: 27, 37-69.
12. Kihara M, Noda K, Kihara M. Distribution of GSTM1 null genotype in relation to gender, age, and smoking status in Japanese lung cancer patients. Pharmacogenetics 1995: 5, S74-S79, 1995.
13. Lin HJ, Han C-Y, Bernstein, Hsiao W, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994: 15, 1077-1081.
14. McLeod HL, Lin J-S, Scott EP, Pui C-H, Evans WE. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 1994: 55, 15-20.
15. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo Z-F, Schwartz BS, Lee B-K, Spitz MR, Wang M, Xu X, Kelsey KT. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995: 16, 1243-1245.
16. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994: 300, 271-276.
17. Seidegard J, Pero RW, Miller DG, Beattie EJ. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986: 7, 751-753.
18. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988: 85, 7293-7297.
19. Warholm M, Alexandrie AK, Hogberg J, Sigvardsson K, Rannug A. Polymorphic distribution of glutathione transferase activity with methyl chloride in human blood. Pharmacogenetics 1994: 4, 307-311.
20. Warholm M, Alexandrie AK, Hogberg J, Sigvardsson K, Rannug A. Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish population. Pharmacogenetics 1995: 5, 252-254.
21. Warwick A, Sarhanis P, Redman C, Pemble S, Taylor JB, Ketterer B, Jones P, Alldersea J, Gilford J, Yengi L, Fryer A, Strange R. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 1994: 15, 2841-2845.
22. Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett G, Wathen CG, Wolf CR, Spurr NK. Glutathione S-transferase mu locus: Use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991: 12, 1533-1537.